AS20010013 | 注射用因福利美 | infliximab | Lyophilized | Biological Products | New Drug Application | 2003-09-19 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Approval Completed-Pending Certificated | 2003-12-17 | view |
JYSB2000342 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2020-07-08 | Janssen Biologics B.V. | Janssen Biologics BV | Certificate Issued | 2020-09-17 | view |
JXSS1000018 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Import Drug Application | 2010-11-04 | Centocor B.V. | Centocor BV | Certificate Issued | 2013-08-22 | view |
JYSB2200076 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2022-04-24 | | | | | view |
JYSB1700012 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2017-02-17 | Janssen Biologics B.V. | Janssen Biologics BV | Certificate Issued | 2018-12-04 | view |
JYSB2000149 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2020-05-09 | Janssen Biologics B.V. | Janssen Biologics BV | In Review | 2020-05-08 | view |
CYSB2200234 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(原2) | Supplementary Application | 2022-09-23 | | Hisun Biopharmaceutical Co Ltd | | | view |
JYSB1500077 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2015-04-10 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2015-09-11 | view |
JYSB2300200 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2023-11-29 | | | | | view |
JYSB1900127 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2019-06-24 | Janssen Biologics B.V. | Janssen Biologics BV | Certificate Issued | 2020-02-26 | view |
JYSB2200199 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2022-10-14 | | | | | view |
JYSB1700005 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2017-01-22 | Janssen Biologics B.V. | Janssen Biologics BV | Certificate Issued | 2017-05-25 | view |
CYSB2400172 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(原2) | Supplementary Application | 2024-07-05 | | Hisun Biopharmaceutical Co Ltd | | | view |
JYSB2000030 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2020-02-19 | Janssen Biologics B.V. | Janssen Biologics BV | Certificate Issued | 2020-04-23 | view |
JYSZ2000024 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | License Renew | 2020-12-28 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2021-07-28 | view |
JYSB1400228 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2014-11-24 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2015-07-13 | view |
CYSB2300117 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(原2) | Supplementary Application | 2023-06-15 | | Taizhou Maibotaike Pharmaceutical Co Ltd | | | view |
JYSB1900061 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2019-03-11 | Janssen Biologics B.V. | Janssen Biologics BV | Certificate Issued | 2019-05-17 | view |
JYSB2000350 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2020-06-30 | Janssen Biologics B.V. | Janssen Biologics BV | Filed | 2020-07-01 | view |
JXSL0700014 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(2) | Import Drug Application | 2007-05-11 | Centocor B.V. | Centocor BV | Certificate Issued | 2008-06-20 | view |